| Presented by: | The Johns Hopkins University School of Medicine |
| Lecturer | Peter J. Mogayzel Jr, MD, PhD, John Paul Clancy, MD and Richard B. Moss, MD |
| Approximate duration: | 2 hrs. |
| Summary points: | This text-based educational program describes the pathophysiology of cystic fibrosis (CF), the multiple complications in patients with CF that need to be managed to improve quality of life and increase survival, the importance of early and aggressive therapies in preventing complications and permanent changes in lung function, the importance of lung function preservation and patient compliance with treatment, and the relationship between nutritional status and lung function in patients with CF. |
| Accreditation: | This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine.
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s).
Expiration date: December 15, 2009. |
| Other: | Text-only CME. |
E-Mail this webcast/CME to a colleague
Aggressive Treatment Strategies in the Fight Against Cystic Fibrosis
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
